01 2Amphastar Nanjing Pharmaceuticals, Inc.
01 1Sodium Taurocholate
02 1Sodium Taurocholate Hydrate
01 2U.S.A
NDC Package Code : 52221-121
Start Marketing Date : 2017-06-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (500g/500g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52221-120
Start Marketing Date : 2017-06-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (500g/500g)
Marketing Category : BULK INGREDIENT
A Sodium taurocholate hydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium taurocholate hydrate, including repackagers and relabelers. The FDA regulates Sodium taurocholate hydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium taurocholate hydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium taurocholate hydrate supplier is an individual or a company that provides Sodium taurocholate hydrate active pharmaceutical ingredient (API) or Sodium taurocholate hydrate finished formulations upon request. The Sodium taurocholate hydrate suppliers may include Sodium taurocholate hydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium taurocholate hydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium taurocholate hydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium taurocholate hydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium taurocholate hydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium taurocholate hydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium taurocholate hydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium taurocholate hydrate suppliers with NDC on PharmaCompass.
We have 1 companies offering Sodium taurocholate hydrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
